|Articles|September 1, 2019
- Pharmaceutical Executive-09-01-2019
- Volume 39
- Issue 9
Pharmaceutical Executive, September 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive September 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 7 years ago
Pharm Exec's 18th Annual Industry Auditalmost 7 years ago
Product Development: The Optimizer’s Cursealmost 7 years ago
Setting Your Launch Pathalmost 7 years ago
Pre-launch Prep: The Modern Protocolalmost 7 years ago
The Murky Outlook for Generic Drugsalmost 7 years ago
Post-Launch Birthday: The Time to Refinealmost 7 years ago
Product Launch: Five Paths Forwardalmost 7 years ago
Once Upon a Brandalmost 7 years ago
Country Report: Chinaalmost 7 years ago
Other Products to WatchAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Modern Policy Concerns Stemming from 340B
2
Taking a Hard Look at Pharma's Traditional Margin Model
3
Funding Roundup: Silence Therapeutics, AbCellera Announce IPO Pricing, Beyang, Remepy Close Series A Financing
4
Pharmaceutical Executive Daily: Mereo BioPharma Enters Option and License Agreement with Sentynl Therapeutics
5